Vascular endothelial growth factor and soluble vascular endothelial growth factor receptor-1 in patients with end-stage renal disease Associations with laboratory findings, comorbidities, and medications


Erturk I., Yesildal F., Acar R., Ozgurtas T., Saglam K.

SAUDI MEDICAL JOURNAL, vol.39, no.6, pp.586-591, 2018 (Peer-Reviewed Journal) identifier

  • Publication Type: Article / Article
  • Volume: 39 Issue: 6
  • Publication Date: 2018
  • Doi Number: 10.15537/smj.2018.6.22024
  • Journal Name: SAUDI MEDICAL JOURNAL
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.586-591

Abstract

Objectives: To show the levels of vascular endothelial growth factor (VEGF), soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) in patients with end-stage renal disease (ESRD) and to show the associations with clinical findings such as demographic features, laboratory findings, comorbidities, and medications.